These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: B lymphocyte subpopulation defined by a rat monoclonal antibody, 14G8.
    Author: Kung JT, Sharrow SO, Ahmed A, Habbersett R, Scher I, Paul WE.
    Journal: J Immunol; 1982 May; 128(5):2049-56. PubMed ID: 6801129.
    Abstract:
    14G8 is monoclonal rat antibody that recognizes an antigen found on 30 to 40% of B lymphocytes from normal mice and on approximately 65% of B lymphocytes from mice with the xid-determined immune defect. 14G8+ B cells from normal mice resemble B cells from mice with the xid-determined defect in that the median amount of membrane IgM expressed per cell is much larger than that of 14G8- B cells. The frequency of 14G8+ cells is highest in neonatal mice (approximately 55% of all spleen cells) and falls with age to approximately 25% of all spleen cells in adult mice. Relatively few lymph node or bone marrow B cells express the antigen recognized by 14G8. 14G8 also reacts with 50% of resident peritoneal cells and with red blood cells. 14G8+ and 14G8- B cell preparations were obtained by fluorescence-activated cell sorting and by adherence to 14G8 coated dishes. 14G8+ cells responded with in vitro proliferation to both anti-mu and to LPS. Cell cycle analysis indicated that approximately 33% of these cells entered S phase in response to LPS and 38% in response to anti-mu. In contrast, 14G8- cells responded poorly to LPS (7% of cells entered S phase) although they showed good responses to anti-mu (40% of cells entered S phase). Thus, 14G8+ B cells, despite their similarity to B cells from mice with the xid defect, can proliferate to anti-mu, which B cells from defective mice fail to do. 14G8 provides a monoclonal antibody valuable in the description of functional B cell subpopulations.
    [Abstract] [Full Text] [Related] [New Search]